Ultra-sensitive ctDNA analysis, tailored to your needs

From trace to truth

Contact Us Today

Pharmaceutical companies

Simsen Diagnostics provides pharmaceutical companies with a seamless, end-to-end ctDNA monitoring service: design, analysis, and interpretation — enabling precise assessment of drug efficacy in real time.

Cancer clinics and hospitals

With Simsen Diagnostics, hospitals and clinics can tailor their approach to personalised ctDNA monitoring: use our custom panels in-house or rely on our complete service for analysis and reporting.

Personalisation

Tumour-informed vs. tumour-naïve

Our process

Versatility and flexibility

Lower costs

Patient stratification. ctDNA informed chemotherapy.

Corporate Customer

2 Min Read

Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial

November 17, 2025 3:30:46 PM CET

Corporate

3 Min Read

How Pharma Companies Can Leverage Simsen Diagnostic’s Tumour-Informed ctDNA Analysis to Transform Cancer Drug Trials

Developing effective cancer treatments is one of the most challenging frontiers in drug development, where ...

November 11, 2025 12:03:55 PM CET

Corporate

1 Min Read

Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025

Simsen Diagnostics is excited to announce our participation in the upcoming GoCo Investor Day, a leading ...

July 9, 2025 3:42:26 PM CEST

Corporate Customer

1 Min Read

Simsen Diagnostics' hospital laboratory solution

We are proud to announce a new partnership with a Swedish hospital, paving the way for transformative ...

June 26, 2025 12:43:00 PM CEST